VYNE Therapeutics Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Mar 2026Filed 03/06/2026 | Jun 2025Filed 14/08/2025 | Mar 2025Filed 03/06/2026 | Sep 2024Filed 07/11/2024 | Jun 2024Filed 14/08/2025 | Mar 2024Filed 08/05/2025 | Sep 2023Filed 07/11/2024 | Jun 2023Filed 14/08/2024 |
|---|---|---|---|---|---|---|---|---|
| $0.1 | $0.1 | $0.2 | $0.1 | $0.2 | $0.1 | $0.1 | $0.1 | |
| −$3.6 | −$5.8 | −$8.6 | −$12 | −$9.4 | −$6.2 | −$6.6 | −$10 | |
| −$0.08 | −$0.13 | −$0.20 | −$0.29 | −$0.22 | −$0.15 | −$2.01 | −$3.09 | |
| — | 43 | — | 43 | 43 | 43 | 3.3 | 3.3 |
Trend